Destruction of rat pancreatic islet beta-cells by cytokines involves the production of cytotoxic aldehydes.

Cytokines produced by mononuclear leukocytes infiltrating pancreatic islets are candidate mediators of islet beta-cell destruction in autoimmune insulin-dependent diabetes mellitus. Cytokines may damage islet beta-cells by inducing oxygen free radical production in the beta-cells. Lipid peroxidation and aldehyde production are measures of oxygen free radical-mediated cell injury. In the current study, we used a HPLC technique to measure levels of different aldehydes produced in rat islets incubated with cytokines. The cytokine combination of interleukin-1beta (10 U/ml), tumor necrosis factor-alpha (10(3) U/ml), and interferon-gamma (10(3) U/ml), and the oxidant, t-butylhydroperoxide, induced significant increases in islet levels of the same aldehydes: butanal, pentanal, 4-hydroxynonenal (4-HNE), and hexanal. Cytokine-induced aldehyde production was associated with islet beta-cell destruction. Thus, cytokine-induced increases in malondialdehyde (MDA; at 4 h) and 4-HNE (at 8 h) preceded islet cell destruction (at 16 h), and the addition of 4-HNE, hexanal, MDA, and pentanal (1-200 microM) to th islets, but not other aldehydes at similar concentrations, produced dose-dependent destruction of islet beta-cells. Furthermore, an antioxidant (lazaroid U78518E) prevented cytokine-induced increases in 4-HNE, hexanal, and MDA and significantly inhibited cytokine-induced decreases in insulin and DNA in the islets. In contrast, N(G)-monomethyl-L-arginine, an inhibitor of nitric oxide synthase, prevented cytokine-induced nitrite production, but did not prevent cytokine-induced increases in 4-HNE, hexanal, and MDA or decreases in insulin and DNA in the islets. These results suggest that cytokines may damage islet beta-cells by inducing oxygen free radicals, lipid peroxidation, and, consequently, the formation of cytotoxic aldehydes in the islet cells.

[1]  J. Cunningham,et al.  Tumor Necrosis Factor-α and Interferon-γ Inhibit Insulin Secretion and Cause DNA Damage in Unweaned-Rat Islets: Extent of Nitric Oxide Involvement , 1996, Diabetes.

[2]  K. Fukunaga,et al.  High-performance liquid chromatographic determination of plasma malondialdehyde level without a solvent extraction procedure. , 1995, Analytical biochemistry.

[3]  C. Epstein,et al.  Transgenic copper/zinc superoxide dismutase modulates susceptibility to type I diabetes. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  J. Lakey,et al.  Human pancreatic islet beta-cell destruction by cytokines is independent of nitric oxide production. , 1994, The Journal of clinical endocrinology and metabolism.

[5]  J. Bach,et al.  Insulin-dependent diabetes mellitus as an autoimmune disease. , 1994, Endocrine reviews.

[6]  H. Drexhage,et al.  Immunohistochemical Characterization of Monocytes-Macrophages and Dendritic Cells Involved in the Initiation of the Insulitis and β-Cell Destruction in NOD Mice , 1994, Diabetes.

[7]  N. Welsh,et al.  Cytokines suppress human islet function irrespective of their effects on nitric oxide generation. , 1994, The Journal of clinical investigation.

[8]  R. Schulz,et al.  Mechanisms of cytokine-induced destruction of rat insulinoma cells: the role of nitric oxide. , 1994, Endocrinology.

[9]  M. Green,et al.  Endogenous nitric oxide induced by interleukin‐1β in rat islets of Langerhans and HIT‐T15 cells causes significant DNA damage as measured by the ‘comet’ assay , 1993, FEBS letters.

[10]  T. Slater,et al.  Measurement of n-alkanals and hydroxyalkenals in biological samples. , 1993, Free radical biology & medicine.

[11]  R. Gross,et al.  Mass spectrometric identification and quantitation of arachidonate-containing phospholipids in pancreatic islets: prominence of plasmenylethanolamine molecular species. , 1993, Biochemistry.

[12]  T. Raffin,et al.  Attenuation of acute lung injury and oxygen radical production by the 21-aminosteroid, U-78518F. , 1993, Journal of applied physiology.

[13]  A. Peck,et al.  Antioxidant enzyme activities in IDD-prone and IDD-resistant mice: a comparative study. , 1993, Free radical biology & medicine.

[14]  M. Poznansky,et al.  Inhibition of superoxide-generating NADPH oxidase of human neutrophils by lazaroids (21-aminosteroids and 2-methylaminochromans). , 1993, Biochemical pharmacology.

[15]  M. Balls,et al.  An improved MTT assay. , 1993, Journal of immunological methods.

[16]  M. Mcdaniel,et al.  Does Nitric Oxide Mediate Autoimmune Destruction of β-Cells?: Possible Therapeutic Interventions in IDDM , 1992, Diabetes.

[17]  R. Nakhleh,et al.  Characterization of T Lymphocytes Infiltrating Human Pancreas Allograft Affected by Isletitis and Recurrent Diabetes , 1992, Diabetes.

[18]  N. Welsh,et al.  Liposomal Delivery of Purified Heat Shock Protein hsp70 Into Rat Pancreatic Islets as Protection Against Interleukin 1β–Induced Impaired β-Cell Function , 1991, Diabetes.

[19]  G. Lepage,et al.  Preparative steps necessary for the accurate measurement of malondialdehyde by high-performance liquid chromatography. , 1991, Analytical biochemistry.

[20]  G. Soldevila Cytotoxic effect of IFN-? plus TNF-a on human islet cells , 1991 .

[21]  L. Harrison,et al.  IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans. , 1988, Journal of immunology.

[22]  K. Amano,et al.  Preferential Infiltration of Macrophages During Early Stages of Insulitis in Diabetes-Prone BB Rats , 1988, Diabetes.

[23]  A. Rabinovitch,et al.  Destruction of Rat Islet Cell Monolayers by Cytokines: Synergistic Interactions of Interferon-γ, Tumor Necrosis Factor, Lymphotoxin, and Interleukin 1 , 1988, Diabetes.

[24]  J. Nerup,et al.  Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity. , 1987, Journal of immunology.

[25]  P. in’t Veld,et al.  Islet morphologic changes. , 1987, Diabetes/metabolism reviews.

[26]  A. Monaco,et al.  An improved method for isolation of mouse pancreatic islets. , 1985, Transplantation.

[27]  T. Mosmann Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.

[28]  S. Tannenbaum,et al.  Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids. , 1982, Analytical biochemistry.

[29]  D. Pipeleers,et al.  Determinants of the selective toxicity of alloxan to the pancreatic B cell. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Marklund,et al.  CuZn-superoxide dismutase, Mn-superoxide dismutase, catalase and glutathione peroxidase in pancreatic islets and other tissues in the mouse. , 1981, The Biochemical journal.

[31]  J. S. Lee,et al.  Review: ethidium fluorescence assays. Part 1. Physicochemical studies. , 1979, Nucleic acids research.

[32]  S. Lenzen,et al.  Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. , 1996, Free radical biology & medicine.

[33]  E. Hall,et al.  Antioxidant action of lazaroids. , 1994, Methods in enzymology.

[34]  H. Esterbauer,et al.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. , 1991, Free radical biology & medicine.

[35]  F. Pociot,et al.  Cytokine and free radicals as effector molecules in the destruction of pancreatic beta cells. , 1990, Current topics in microbiology and immunology.

[36]  K. Asayama,et al.  Effect of vitamin E deficiency and selenium deficiency on insulin secretory reserve and free radical scavenging systems in islets: decrease of islet manganosuperoxide dismutase. , 1986, The Journal of laboratory and clinical medicine.

[37]  J. Hamburger [Insulin-dependent diabetes, an autoimmune disease]. , 1986, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[38]  T. Slater Free-radical mechanisms in tissue injury. , 1984, The Biochemical journal.